In an interview with Applied Clinical Trials Associate Editor Don Tracy, Shakthi Kumar, chief strategy & business officer, ...

A researcher in the IU Luddy School of Informatics, Computing and Engineering in Indianapolis is leading efforts to develop ...

Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...

Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...

Tuva Health, the world's first open-source healthcare data transformation platform, today announced it has partnered with MultiCare Connected Care (MCC), MultiCare Health System’s accountable care ...

To avoid a tug-of-war between scientific rigour and operational efficiency, we must focus on the user and data journeys of ...

By working together, healthcare providers, policymakers and technology vendors can create a more connected healthcare system ...

While death rates from cardiovascular disease have declined 60% since 1950, a recent upward trend aligns with increases in ...

INDIANAPOLIS, February 11, 2025--hc1 + Accumen introduced its next-generation Clinical Excellence solutions today, a ...

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...

As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.

As genomic technologies become more accessible, they have the potential to reduce healthcare disparities and improve equity ...